Top Markets
#1 MowCat MowCat +48.41%
#2 Bermuda Shorts Bermuda Shorts +26.38%
#3 Velvet Velvet +22.97%
#4 Fake World Assets Fake World Assets +20.31%
#5 Quack AI Quack AI +18.88%
#6 Biconomy Biconomy +18.48%
#7 Derive Derive +16.72%
#8 Perle Perle +15.52%
#9 Block Street Block Street +15.33%
#10 DUSK Network DUSK Network +14.05%
Coin of the day
MowCat MowCat
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Mustang Bio, Inc. Mustang Bio, Inc.

Mustang Bio, Inc.

MBIO
Pozycja w akcjach #35075
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on... Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children’s hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
Cena akcji
$0.594
Ostatnia synchronizacja: 2026-08-14
Kapitalizacja rynkowa
$4.50M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-66.44%
Kraj
US
Handel Mustang Bio, Inc. (MBIO)

Kategoria

Healthcare
Historia ceny akcji dla Mustang Bio, Inc. (MBIO)
Najwyższa cena zamknięcia: $0.60 dnia 2026-08-01

Najniższa cena zamknięcia: $8.92K dnia 2017-08-01
Historia cen akcji firmy Mustang Bio, Inc. od 2017 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -10.26%
2025 -87.55%
2024 -86.83%
2023 -76.52%
2022 -79.00%
2021 -45.05%
2020 -1.99%
2019 18.38%
2018 -73.75%
2017 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE